The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Pfizer
 
Employment - Pfizer
First-line avelumab + axitinib therapy in patients (pts) with advanced renal cell carcinoma (aRCC): Results from a phase Ib trial.
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
James M. G. Larkin
No Relationships to Disclose
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma
 
Fiona C. Thistlethwaite
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Nordic Bioscience
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Marcella Martignoni
No Relationships to Disclose
 
Paul D. Nathan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Immunocore; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Thomas Powles
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Paul B. Robbins
Employment - AstraZeneca; Pfizer
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer
Research Funding - AstraZeneca; Pfizer
Patents, Royalties, Other Intellectual Property - AstraZeneca
 
David D. Chism
Stock and Other Ownership Interests - Biogen (I)
Travel, Accommodations, Expenses - Lilly
 
Daniel C. Cho
Honoraria - Bristol-Myers Squibb; Exelixis; Genentech
Consulting or Advisory Role - Pfizer; Prometheus
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alkermes; Amgen; Bristol-Myers Squibb; C-Cam; Genentech; Genoptix; GlaxoSmithKline; Infinity Pharmaceuticals; Lilly; Merck; Nektar; Novartis; Pfizer; X4 Pharma
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; WCCT Global
Consulting or Advisory Role - Castle Biosciences; Deciphera; RedHill Biopharma
Research Funding - Abbvie (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Calithera Biosciences (Inst); Celldex (Inst); Deciphera (Inst); Endocyte (Inst); ESSA (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Plexxikon (Inst); Seagen (Inst); Sirtex Medical (Inst); Tokai Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Consulting or Advisory Role - Keryx (I)
Research Funding - Hydrocephalus Clinical Research Network (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Keryx (I)
 
Hirotsugu Uemura
Honoraria - Novartis; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bayer; Janssen; Novartis; Ono Pharmaceutical
Speakers' Bureau - Bayer; Novartis; Sanofi
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Novartis; Ono Pharmaceutical; Pfizer; Takeda
 
Yoshihiko Tomita
Honoraria - Astellas Pharma; Novartis; Ono Pharmaceutical; Pfizer; Sanofi
Consulting or Advisory Role - Novartis; Ono Pharmaceutical
Research Funding - Astellas Pharma; AstraZeneca; Pfizer
 
Anna Compagnoni
Employment - Chiesi; Pfizer
Stock and Other Ownership Interests - Pfizer
 
Alessandra di Pietro
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer